Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

MIRA MIRA Pharmaceuticals Inc

0,8501

-0,0349 (-3,94%)

29 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

MIRA Pharmaceuticals (NASDAQ:MIRA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more MIRA Pharmaceuticals Charts.

MIRA Pharmaceuticals (NASDAQ:MIRA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more MIRA Pharmaceuticals Charts.

News MIRA Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 22 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog
Dienstag 21 Mai 2024 (1 Woche vor) • PR Newswire (US)

Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
Montag 20 Mai 2024 (1 Woche vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
Dienstag 2 April 2024 (2 Monate vor) • PR Newswire (US)

MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
Donnerstag 21 März 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 7 März 2024 (3 Monate vor) • Edgar (US Regulatory)

MIRA Pharmaceuticals Provides Corporate Update
Montag 5 Februar 2024 (4 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Mittwoch 17 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 28 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 27 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 27 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere MIRA Pharmaceuticals Inc News-Artikel

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen